Cancer Diagnosis and Treatment
Peer reviewed
Abstract
Abstract
Background: Carcinoma of unknown primary (CUP) remains a heterogeneous disease, with poor survival outcomes and limited data from Thailand. Objective: To describe clinical characteristics, clinicopathologic features, treatment patterns, progression-free survival (PFS), overall survival (OS), and to identify prognostic factors of patients with CUP. Materials and Methods: A retrospective study was conducted on patients diagnosed with CUP between January 2012 and December 2022 at Khon Kaen Cancer Center, Khon Kaen Hospital. Patients were categorized into favorable- or unfavorable-risk subsets according to ESMO criteria. Results: Among 102 patients, the median age was 60.7 years, and 64.7% were male. Disseminated disease was present in 86.3%, and adenocarcinoma (56.86%) was the most common histology, and favorable-risk subsets accounted for 72.5%. The median PFS for the favorable-risk groups and the unfavorable-risk group were 7 months vs. 1 month (p<0.001), respectively. The median OS for favorable-risk groups and unfavorable-risk groups were 17 months vs. 2 months (p<0.001), respectively. Most treated patients received empirical platinum-based chemotherapy, predominantly paclitaxelplatinum combinations. In multivariable analysis, disease extent (localized vs. disseminated) and smoking status (smoke vs. non-smoke) were the only independent prognostic factors for OS and PFS. Conclusion: This real-world CUP cohort shows patients with favorable risk groups have better survival outcomes than unfavorable risk groups, with survival comparable to specialized international series. Disease extent and smoking status emerged as the only independent prognostic factors.
Direct answer
What can I do from this paper page?
Use this page to scan "Clinical Characteristics and Survival Outcomes in Patients with Cancer of Unknown Primary Site (CUP): A Retrospective Cohort Study" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Cancer Diagnosis and Treatment research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Thongthieang2026Clinical,
title = {Clinical Characteristics and Survival Outcomes in Patients with Cancer of Unknown Primary Site (CUP): A Retrospective Cohort Study},
author = {Luangyot Thongthieang},
journal = {Journal of the Medical Association of Thailand},
year = {2026},
doi = {10.35755/jmedassocthai.2026.9.04408},
url = {https://doi.org/10.35755/jmedassocthai.2026.9.04408}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Cancer Diagnosis and Treatment research papers?
Follow Cancer Diagnosis and Treatment research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Clinical Characteristics and Survival Outcomes in Patients with Cancer of Unknown Primary Site (CUP): A Retrospective Cohort Study. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app